Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

On CRSP's fourth-quarter 2024 earnings call, investors' focus will likely be on the sales figure of Casgevy, its first marketed product.

Bristol Myers Squibb's FDA nod for Breyanzi (liso-cel) in relapsed/refractory CLL/SLL boosts its CAR T-cell portfolio, ...

Genesis announced that it has completed its second successful human transplant with a genetically engineered pig kidney, with ...

The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...

A new approach that used CRISPR to engineer adipocytes and implant them in mice models of cancer reduced cancer progression.

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly is expanding the ...

Racial disparities in mortality are increasing. This article explores how the production of DNA-edited ethnically diverse ...

Scientists have successfully developed a gastric cancer model using 3D bioprinting technology and patient-derived cancer tissue fragments. This innovative model preserves the characteristics of actual ...

Protein synthesis is vital for life, translating genetic information from DNA to functional proteins through transcription ...

The Youth Empowerment Services (YES) Waiver program serves as an alternative to foster care, but stagnant Medicaid reimbursement rates have lead to provider shortages. Other news from around the ...